You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 3, 2026

Claims for Patent: 11,266,743


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,266,743
Title:Peptide compositions and methods of use thereof
Abstract:Described herein are membrane permeabilizing peptides and antimicrobial peptides, polynucleotides encoding the peptides, and compositions containing the peptides. Furthermore, described herein are methods for using the peptides, polynucleotides, and compositions for research, diagnosis, and therapy.
Inventor(s):Wimley William Charles, Starr Charles Gannon, Kauffman William Berkeley
Assignee:The Administrators of the Tulane Educational Fund
Application Number:US16758791
Patent Claims:

Details for Patent 11,266,743

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Microbix Biosystems Inc. KINLYTIC urokinase For Injection 021846 January 16, 1978 11,266,743 2038-10-25
Recordati Rare Diseases, Inc. ELSPAR asparaginase For Injection 101063 January 10, 1978 11,266,743 2038-10-25
Amgen Inc. NEUPOGEN filgrastim Injection 103353 February 20, 1991 11,266,743 2038-10-25
Amgen Inc. NEUPOGEN filgrastim Injection 103353 June 28, 2000 11,266,743 2038-10-25
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.